Cambridge Investment Research Advisors, Inc. First Tr ETF Vi Nasdaq Pharmac Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	SELL	$25.44 - $27.16 $207,361 - $221,381	-8,151 Reduced 34.36%	15,572 $408,000
Q1 2023 May 11, 2023	BUY	$25.25 - $28.3 $146,652 - $164,366	5,808 Added 32.42%	23,723 $619,000
Q4 2022 Feb 08, 2023	BUY	$24.01 - $28.45 $430,139 - $509,681	17,915 New	17,915 $491,000

Others Institutions Holding FTXH

# of Institutions

Shares Held

261K

Call Options Held

Put Options Held

Lpl Financial LLC Fort Mill, SC

51.1K
Shares

$1.42 Million
0.0% of portfolio
Goldman Sachs Group Inc New York, NY

47.8K
Shares

$1.33 Million
0.0% of portfolio
Susquehanna International Group, LLP Bala Cynwyd, PA

43.3K
Shares

$1.2 Million
0.0% of portfolio
New Edge Advisors, LLC New Orleans, LA

21.4K
Shares

$593,103
0.0% of portfolio
Envestnet Asset Management Inc

14K
Shares

$389,447
0.0% of portfolio

View Full List

About FIRST TR ETF VI NASDAQ PHARMAC

Ticker FTXH
Sector ETFs
Industry ETFs

More about FTXH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account